“黑名单”打响反贿升级战

Black List Triggers the Battle of Anti-Corruption

医药和医疗器械企业一旦进入“黑名单”，并向社会公布，就意味着企业将失去整个中国市场。

The Beijing Health Bureau for the first time released the list of 21 enterprises that have bad records in medicine purchase and sale corruption on 26, November. This move gives a heavy blow to the corruption occurred in medicine purchase and sales by public opinion, market access and legal sanction from the very beginning and evokes direct responses within the industry. Although the long effectiveness is the key factor to the measure, it indicates the government redoubles its effort to cope with the business corruption in medicine purchase and sale area.